KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.

  • Amgen's Change in Receivables rose 32727.27% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.7 billion, marking a year-over-year increase of 70680.27%. This contributed to the annual value of $2.7 billion for FY2025, which is 70680.27% up from last year.
  • Latest data reveals that Amgen reported Change in Receivables of $1.1 billion as of Q4 2025, which was up 32727.27% from -$222.0 million recorded in Q3 2025.
  • In the past 5 years, Amgen's Change in Receivables registered a high of $1.3 billion during Q1 2025, and its lowest value of -$486.0 million during Q1 2024.
  • Over the past 5 years, Amgen's median Change in Receivables value was $178.0 million (recorded in 2022), while the average stood at $221.2 million.
  • As far as peak fluctuations go, Amgen's Change in Receivables soared by 45178.57% in 2022, and later plummeted by 43750.0% in 2024.
  • Amgen's Change in Receivables (Quarter) stood at $160.0 million in 2021, then rose by 12.5% to $180.0 million in 2022, then skyrocketed by 140.56% to $433.0 million in 2023, then crashed by 209.24% to -$473.0 million in 2024, then skyrocketed by 327.27% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q4 2025, -$222.0 million for Q3 2025, and $515.0 million during Q2 2025.